Business | 2014.06.11
SomaLogic Announces First Early-access Site for SOMAscan™ Assay
BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., announced today that the Perelman School of Medicine at the University of Pennsylvania is the first biomedical research center that will offer researchers on-site access to the SOMAscan™ assay, the most powerful proteomics platform available today. The assay will be performed at Penn’s Institute for Translational Medicine and Therapeutics (ITMAT), under the leadership of Daniel J. Rader, MD, associate director of ITMAT and chair of the Departmen
For more information, please visit
http://www.businesswire.com/news/home/20[...]s-Site-SOMAscan%E2%84%A2-Assay
